In Vivo Effects of IL-4, IL-10, and Amifostine on Cytokine Production in Patients with Acute Myelogenous Leukemia

References

• Tsuzuki M, Ezaki K, Maruyama F, Ino T, Kojima H, Okamoto M, Yamaguchi T, Nomura T, Miyazaki H, Wakita M, Matsui T, Hirano M. Proliferative effects of several hematopoietic growth factors on acute myelogenous leukemia cells and correlation with treatment outcome. Leukemia 1997; 11: 2125–30
   PubMed Web of Science ®Google Scholar
• Murayama T, Imoto S, Natazuka T, Chihara K, Matsui T. Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF, GM-CSF, M-CSF, SCF and TPO. Leukemia Research 1998; 22: 557–60
   PubMed Web of Science ®Google Scholar
• Viallard J F, Grosset C, Lacombe F, David S, Mahon F X, Barbot C, Vianes I, Dupouy M, Reiffers J. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside. Leukemia Research 1996; 20: 915–23
   PubMed Web of Science ®Google Scholar
• Westermann F, Kube D, Haier B, Bohlen H, Engert A, Zuehlsdorf M, Diehl V, Tesch H. Interleukin 10 inhibits cytokine production of human AML cells. Annals of Oncology 1996; 7: 397–404
   PubMed Web of Science ®Google Scholar
• Preisler H D, Bi S, Venugopal P, Raza A. Cytokines, molecular biological abnormalities, and acute myelogenous leukemia. Leukemia Research 1997; 21: 299–312
   PubMed Web of Science ®Google Scholar
• Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw A R, Dinarello C A, Cozzolino F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991; 78: 3248–53
   PubMed Web of Science ®Google Scholar
• Yin M, Gopal V, Banavali S, Gartside P, Preisler H. Effects of an IL-1 receptor antagonist on acute myeloid leukemia cells. Leukemia 1992; 6: 898–901
   PubMed Web of Science ®Google Scholar
• Hoang T, Levy B, Onetto N, Haman A, Rodriguez-Cimadevilla J C. Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. Journal of Experimental Medicine 1989; 170: 15–26
   PubMed Web of Science ®Google Scholar
• Elbaz O, Budel L M, Hoogerbrugge H, Touw I P, Delwel R, Mahmoud L A, Lowenberg B. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood 1991; 77: 989–95
   PubMed Web of Science ®Google Scholar
• Elbaz O, Mahmoud L A. Tumor necrosis factor and human acute leukemia. Leukemia and Lymphoma 1994; 12: 191–5
   PubMed Web of Science ®Google Scholar
• Carter A, Silvian-Draxler I, Tatarsky I. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia. American Journal of Hematology 1992; 40: 245–51
   PubMed Web of Science ®Google Scholar
• Bruserud O. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts. Leukemia 1996; 10: 1497–1503
   PubMed Web of Science ®Google Scholar
• Harada M, Akashi K, Shibuya T, Takamatsu Y, Niho Y. Role of interleukin-4 in the negative regulation of proliferation of chronic myelomonocytic leukemia cells. Annals of the New York Academy of Sciences 1991; 628: 156–64
   PubMed Web of Science ®Google Scholar
• Akashi K, Shibuya T, Harada M, Takamatsu Y, Uike N, Eto T, Niho Y. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells. Journal of Clinical Investigation 1991; 88: 223–30
   PubMed Web of Science ®Google Scholar
• Estrov Z, Kurzrock R, Talpaz M. Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia. Leukemia and Lymphoma 1993; 10: 407–18
   PubMed Web of Science ®Google Scholar
• Asano Y, Shibata S, Kobayashi S, Okamura S, Niho Y. Interleukin-10 inhibits the autocrine growth of leukemic blast cells from patients with acute myeloblastic leukemia. International Journal of Hematology 1997; 66: 445–50
   PubMed Web of Science ®Google Scholar
• Geissler K, Ohler L, Fodinger M, Virgolini I, Leimer M, Kabrna E, Kollars M, Skoupy S, Bohle B, Rogy M, Lechner K. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. Journal of Experimental Medicine 1996; 184: 1377–84
   PubMed Web of Science ®Google Scholar
• Iversen P O, Hart P H, Bonder C S, Lopez A F. Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells. Cancer Research 1997; 57: 476–80
   PubMed Web of Science ®Google Scholar
• Bruserud O, Tore Gjertsen B, Brustugun Terje O, Bassoe C F, Nesthus I, Akselsen Espen P, Buhring H J, Pawelec G. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 1995; 9: 1910–20
   PubMed Web of Science ®Google Scholar
• Estrov Z, Kurzrock R, Talpaz M. Cytokines and their antagonists in myeloid disorders. Seminars in Hematology 1995; 32: 220–31
   PubMed Web of Science ®Google Scholar
• List A F. Use of amifostine in hematologic malignancies, myelodysplastic syndrome, and acute leukemia. Seminars in Oncology 1999; 26(2 Suppl 7)61–5
   PubMed Web of Science ®Google Scholar
• List A F, Heaton R, Glinsmann-Gibson B, Capizzi R L. Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors. Leukemia 1998; 12: 1596–602
   PubMed Web of Science ®Google Scholar
• Douay L, Hu C, Giarratana M C, Bouchet S, Conlon J, Capizzi R L, Gorin N C. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging. Blood 1995; 86: 2849–55
   PubMed Web of Science ®Google Scholar
• Huang X -K, Gao X -Z, Burke P, Raza A, Preisler H D. The effects of amifostine on the clonogenic proliferation in vitro of myelodysplastic and acute and chronic myelogenous leukemia cells. Proceedings of American Society of Clinical Oncology 1997; 16: 514a
   Google Scholar
• Puri R K. Structure and function of interleukin-4 and its receptor. Cancer Treatment and Research 1995; 80: 143–85
   PubMedGoogle Scholar
• Beckmann M P, Cosman D, Fanslow W, Maliszewski C R, Lyman S D. The interleukin-4 receptor: structure, function, and signal transduction. Chemical Immunology 1992; 51: 107–34
   PubMed Web of Science ®Google Scholar
• Howard M, O'Garra A. Biological properties of interleukin 10. Immunology Today 1992; 13: 198–200
   PubMedGoogle Scholar
• Paul W E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77: 1859–70
   PubMed Web of Science ®Google Scholar
• Hamaguchi Y, Kanakura Y, Fujita J, Takeda S, Nakano T, Tarui S, Honjo T, Kitamura Y. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. Journal of Experimental Medicine 1987; 165: 268–73
   PubMed Web of Science ®Google Scholar
• MacNeil I A, Suda T, Moore K W, Mosmann T R, Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. Journal of Immunology 1990; 145: 4167–73
   PubMed Web of Science ®Google Scholar
• Moore K W, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann T R. Interleukin-10. Annual Review of Immunology 1993; 11: 165–90
   PubMed Web of Science ®Google Scholar
• Rennick D, Hunte B, Dang W, Thompson-Snipes L, Hudak S. Interleukin-10 promotes the growth of megakaryocyte, mast cell, and multilineage colonies: analysis with committed progenitors and ThylloScal+ stem cells. Experimental Hematology 1994; 22: 136–41
   PubMed Web of Science ®Google Scholar
• Peschel C, Paul W E, Ohara J, Green I. Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood 1987; 70: 254–63
   PubMed Web of Science ®Google Scholar
• Henschler R, Mantovani L, Oster W, Lubbert M, Lindemann A, Mertelsmann R, Herrmann F. Interleukin-4 regulates mRNA accumulation of macrophage-colony stimulating factor by fibroblasts: synergism with interleukin-1 beta. British. Journal of Haematology 1990; 76: 7–11
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Koji T, Miyoshi S. Modification of expression of stem cell factor by various cytokines. Journal of Cellular Physiology 1999; 181: 285–94
   PubMed Web of Science ®Google Scholar
• Denizot Y, Besse A, Raher S, Nachat R, Trimoreau F, Praloran V, Godard A. Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8 and leukemia inhibitory factor by human bone marrow stromal cells. Biochimica et Biophysica Acta 1999; 1449: 83–92
   PubMed Web of Science ®Google Scholar
• Castejon R, Vargas J A, Romero Y, Briz M, Munoz R M, Durantez A. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia. Cytometry 1999; 38: 224–30
   PubMedGoogle Scholar
• Banchereau J. Converging and diverging properties of human interleukin-4 and interleukin-10. Behring Institute Mitteilungen 1995; 96: 58–77
   PubMedGoogle Scholar
• Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Annals of the New York Academy of Sciences 1993; 685: 713–39
   PubMed Web of Science ®Google Scholar
• Tao M, Li B, Nayini J, Andrews C B, Huang R -W, Devemy E, Song S, Venugopal P, Preisler H D. SCF, IL-1b, IL-1ra, and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients. Cytokine 2000; 12: 699–707
   PubMed Web of Science ®Google Scholar
• Sawada K, Leko M, Notoya A, Tarumi T, Koizumi K, Kitayama S, Nishio H, Fukada Y, Yasukouchi T, Yamaguchi M, Katoh S, Koike T. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells. Blood 1996; 88: 319–27
   PubMed Web of Science ®Google Scholar
• Hassan H T, Zander A. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematologica 1996; 95: 257–62
   PubMed Web of Science ®Google Scholar
• Bendall L J, Makrynikola V, Hutchinson A, Bianchi A C, Bradstock K F, Gottlieb D J. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals. Leukemia 1998; 12: 1375–82
   PubMed Web of Science ®Google Scholar
• Cimino G, Amadori S, Cava M C, De Sanctis V, Petti M C, Di Gregorio A O, Sgadari C, Vegna L, Cimino G, Mandelli F. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients. Leukemia 1991; 5: 32–5
   PubMed Web of Science ®Google Scholar
• Oster W, Cicco N A, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann R H, Herrmann F. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. Journal of Clinical Investigation 1989; 84: 451–7
   PubMed Web of Science ®Google Scholar
• Murohashi I, Rodriguez-Cimadevilla J C, Hoang T. Tumor necrosis factor-alpha enhances cytokine production by AML blasts. Annals of New York Academy of Sciences 1991; 628: 148–50
   PubMed Web of Science ®Google Scholar
• Cimino G, Annino L, Giona F, Sgadari C, Di Gregorio A O, Cava M C, Cimino G, Mandelli F. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia. Leukemia 1991; 5: 602–5
   PubMed Web of Science ®Google Scholar
• Sallerfors B, Olofsson T. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia. British Journal of Haematology 1991; 78: 343–51
   PubMed Web of Science ®Google Scholar